Clinical Trials for Thymoma

Find clinical trials for thymoma. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

NCT ID: NCT01950572

This clinical trial is focused on studying patients with malignant mesothelioma, a type of cancer that affects the lining of the lungs and other organs. The goal of the study is to collect samples ...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT ID: NCT03556228

This clinical trial is studying a new medication called VMD-928, which is being tested for patients with certain types of advanced cancers and lymphomas that have not responded to standard treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States, Duarte, California, United States +32 more

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

NCT ID: NCT06248515

This clinical trial is investigating a medication called sacituzumab govitecan for adults with advanced thymoma and thymic carcinoma, which are rare types of tumors originating in the thymus gland....

Recruiting

Phase: PHASE2 Type: interventional Locations: Hackensack, New Jersey, United States, Palo Alto, California, United States +1 more

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

NCT ID: NCT06838910

This clinical trial is studying a new treatment approach for patients with thymoma and thymic carcinoma who have not responded well to their initial chemotherapy. The trial will test a combination ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Nanjing, Jiangsu, China

Molecular Analysis of Thoracic Malignancies

NCT ID: NCT01385722

This is a long-term, observational study called “Molecular Analysis of Thoracic Malignancies” at Stanford. Researchers are collecting blood, tumor tissue, normal tissue, and other body fluids to le...

Enrolling by invitation

Type: observational Locations: Stanford, California, United States

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

NCT ID: NCT06730308

This clinical trial is studying a treatment for patients with thymoma, a type of tumor that forms in the thymus gland and can sometimes be difficult to treat. Specifically, the study is looking at ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guanzhou, Guangdong, China

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

NCT ID: NCT06692062

This clinical trial is studying a type of radiation therapy called hypofractionated radiotherapy to see if it can effectively treat thymic epithelial tumors, which include thymoma and thymic carcin...

Recruiting

Phase: NA Type: interventional Locations: Changsha, Hunan, China

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

NCT ID: NCT05214612

This clinical trial is studying a condition called Myasthenia Gravis (MG), which affects the nervous system and can cause muscle weakness. The goal of the study is to better understand the differen...

Recruiting

Type: observational Locations: Assiut, Egypt

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

NCT ID: NCT06301945

This clinical trial is focused on improving the diagnosis and treatment of thymic epithelial tumors, which are rare types of tumors found in the chest. The researchers are developing a tool that us...

Recruiting

Type: observational Locations: Rotterdam, South Holland, Netherlands

Robot-assisted vs VATS for Thymoma

NCT ID: NCT06029621

This clinical trial is comparing two types of surgery for patients with a condition called thymoma, which is a tumor in the thymus gland located in the chest. The study aims to find out if robot-as...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China, Zhejiang, China

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

NCT ID: NCT02633553

This clinical trial is looking at how effective adjuvant radiotherapy (a type of treatment using high-energy rays) is for patients with stage II or III thymoma after their tumors have been complete...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions